Facebook Linkedin Twitter
Inside Precision Medicine AviadoBio and Astellas Ink Potential $2.5B+ Deal for Frontotemporal Dementia Candidate 

Astellas

3d illustration of the human brain with visible blood vessels illustrating Alzheimer's disease and dementia.
News & Features

AviadoBio and Astellas Ink Potential $2.5B+ Deal for Frontotemporal Dementia Candidate 

0
CAR T cell immunotherapy, illustration
News & Features

Astellas and Poseida Ink $50M CAR-T Deal

0
Rapamycin inhibiting protein kinase mTORC1
News & Features

Astellas and PeptiDream Ink $21M Plus Protein Degrader Deal 

0
Astellas Inks Ophthalmic Gene Therapy Deal Worth Potentially $940M Plus with 4D Molecular
News & Features

Astellas Inks Ophthalmic Gene Therapy Deal Worth Potentially $940M Plus with 4D Molecular

0
DNA Abstract Background
News & Features

Out of the Gate: Kate Tx Nets $51M And Astellas Gene Therapy Deal

0
Micrograph of Renal Cell Carcinoma (RCC)
News & Features

Astellas and Sony Ink Deal to Make ADCs with Novel Platform

0
Ophthalmologist examining an older Black, male patient's eyes to carry out retinal imaging to look for diabetic retinopathy.
News & Features

Astellas Acquires Eye-Disease Specialist Iveric for Almost $6B

0
3D Rendering of Antibody Drug Conjugate Molecules
News & Features

Leap Therapeutics Absorbs Flame Biosciences for Targeted Oncology Pipeline

0
Body with gastric cancer tumor
News & Features

Astellas Zolbetuximab Trial Results Cement CLDN18.2 as Gastric-Cancer Biomarker  

0
Ear - Anatomy to represent hearing loss
News & Features

Mogrify, Astellas Collaboration to Examine In Vivo Regenerative Medicine Treatment Approaches to Hearing Loss

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine